Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
21 U.S.C. 379aa Serious adverse event reporting for nonprescription drugs
21 U.S.C. 379aa Serious adverse event reporting for nonprescription drugs, “Serious adverse event reporting for nonprescription drugs”, is a U.S. Code section of Part H—Serious Adverse Event Reports; in force.
https://ontology.bommaritollc.com/id/01a0f06c-cdef-72da-b70b-9f4e966513a5
Elsewhere
Facts
| adms:identifier | |
| eli:cites | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 21 U.S.C. 379aa |
| schema:legislationJurisdiction | |
| schema:legislationLegalForce | |
| schema:legislationType | |
| schema:name | Serious adverse event reporting for nonprescription drugsen |
| schema:url | |
| skos:prefLabel | 21 U.S.C. 379aa Serious adverse event reporting for nonprescription drugsen |
Related
Cited by (4)eli:cites
- 21 U.S.C. 331 Prohibited acts
- 21 U.S.C. 352 Misbranded drugs and devices
- 21 U.S.C. 353 Exemptions and consideration for certain drugs, devices, and biological products
- 21 U.S.C. 381 Imports and exports